Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SOUTH SAN FRANCISCO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced nine presentations at the European Society of Cardiology Heart Failure 2026...
-
SAN FRANCISCO, April 23, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial...
-
April 23, 2026 Bridge Plus was designed for rare, life-threatening emergencies to help control bleeding during superior vena cava (SVC) tears, which occur in <0.5% of lead extraction procedures...
-
Significant lowering of systolic blood pressure of 9mmHg on top of background treatment maintained with GMRx2 over an average follow-up of 3 years Safety findings similar to previous studies of GMRx2 ...
-
ST. LOUIS, April 22, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first...
-
Advances in cardiac technology and rising healthcare awareness are reshaping the future of the global pacemakers market.
-
AliveCor launches AI-Powered Kardia 12L in Europe, the world’s first handheld 12-Lead ECG with a unique single-cable design.
-
MOUNTAIN VIEW, California, April 08, 2026 (GLOBE NEWSWIRE) -- AliveCor, công ty hàng đầu trên toàn cầu trong lĩnh vực tim mạch ứng dụng AI, hôm nay đã công bố việc đăng ký lưu hành hệ thống điện tâm...
-
AliveCor announces the launch of Kardia™ 12L ECG System powered by KAI™ 12L AI in Vietnam, expanding AI-enabled cardiac diagnostics across Southeast Asia
-
Minneapolis, MN, USA and Paris, France and Munich, Germany, 7 April 2026 – TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation,...